𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Azacitidine in untreated acute myeloid leukemia: A report on 149 patients

✍ Scribed by Thépot, Sylvain; Itzykson, Raphael; Seegers, Valerie; Recher, Christian; Raffoux, Emmanuel; Quesnel, Bruno; Delaunay, Jacques; Cluzeau, Thomas; Marfaing Koka, Anne; Stamatoullas, Aspasia; Chaury, Marie-Pierre; Dartigeas, Caroline; Cheze, Stéphane; Banos, Anne; Morel, Pierre; Plantier, Isabelle; Taksin, Anne-Laure; Marolleau, Jean Pierre; Pautas, Cecile; Thomas, Xavier; Isnard, Francoise; Beve, Blandine; Chait, Yasmine; Guerci, Agnes; Vey, Norbert; Dreyfus, Francois; Ades, Lionel; Ifrah, Norbert; Dombret, Herve; Fenaux, Pierre; Gardin, Claude

Book ID
121714824
Publisher
John Wiley and Sons
Year
2014
Tongue
English
Weight
549 KB
Volume
89
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Arsenic trioxide and low-dose cytarabine
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia
✍ Gail J. Roboz; Ellen K. Ritchie; Tania Curcio; Juliette Provenzano; Rebecca Carl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

## Abstract ## BACKGROUND. Acute myeloid leukemia (AML) carries a dismal prognosis in older patients. In this study, the authors evaluated the safety and efficacy of arsenic trioxide combined with low‐dose cytarabine in untreated patients aged ≥60 years with AML. ## METHODS. In a phase 1/2 desig